4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Inhibin, activin, and follistatin. Potential roles in ovarian physiology.

      Annals of the New York Academy of Sciences
      Animals, Embryonic and Fetal Development, genetics, Female, Follistatin, Gene Expression, Glycoproteins, physiology, Gonadotropins, Humans, Inhibins, Ovary

      Read this article at

      ScienceOpenPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The physiological significance of these results will not become clear until patterns of activin and inhibin protein production and the expression of their receptors have been more thoroughly characterized in relation to follicular development. Meanwhile, in situ hybridization studies on rat and monkey ovaries suggest that inhibin/activin beta-subunit mRNA (favoring synthesis of activin) is relatively abundant in granulosa cells of immature antral follicles, whereas alpha-subunit mRNA (favoring synthesis of inhibin) predominates in Graafian follicles. The increased production of follistatin associated with advanced preovulatory development would serve to further reduce the activin "tone" relative to inhibin (Fig. 1). At the level of protein action in vitro, the pattern emerging is that inhibin minimally affects granulosa cell steroidogenesis at any stage of follicular development, whereas activin has pronounced modulatory effects that alter with follicular maturity. As suggested previously,60 the ability of activin to enhance gonadotropin-responsive aromatase activity and simultaneously suppress progesterone production by mature granulosa cells has physiological implications in that it hints at a mechanism for promoting estrogen synthesis and simultaneously suppressing progesterone synthesis, which is precisely what occurs in the preovulatory follicle. The effects of inhibin and activin on human thecal androgen synthesis observed in vitro suggest how these proteins might act locally to modulate preovulatory follicular growth and estrogen synthesis in vivo (Fig. 2).57 In essence, we propose that activin acting at early stages of antral follicular development plays a role in follicular recruitment through sensitizing immature granulosa cells to the cytodifferentiative action of FSH. On the other hand, inhibin is more likely to play a role in preovulatory follicular selection and maintenance of follicular dominance. Studies of follicular fluid levels of androgen and estrogen in relation to granulosa cell aromatase activity indicate that the capacity of the theca interna to generate aromatase substrate (androstenedione) increases hand in hand with aromatase activity in the human preovulatory follicle. It has therefore been suggested that a positive feedback loop (granulosa on theca) exists that promotes thecal androgen synthesis and hence estrogen synthesis in this follicle.64 The discovery that inhibin production in vitro is greatest by granulosa cells isolated from preovulatory follicles strongly implicates inhibin as a component of this feedback loop.

          Related collections

          Most cited references29

          • Record: found
          • Abstract: found
          • Article: not found

          Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin.

          Inhibin is a gonadal protein that specifically inhibits the secretion of pituitary follicle-stimulating hormone (FSH). Two forms of inhibin (A and B) have been purified from porcine follicular fluid and characterized as heterodimers of relative molecular mass (Mr) 32,000 (ref. 2). Each inhibin is comprised of an identical alpha-subunit of Mr 18,000 and a distinct but related beta-subunit of Mr 13,800-14,700 linked by interchain disulphide bond(s). Throughout the purification of inhibins, we consistently observed two fractions which stimulated the secretion of pituitary FSH. We report here the isolation of one of the FSH-releasing proteins; it has a Mr of 24,000 and its N-terminal sequences up to residue 32 are identical to those of each beta-subunit of inhibins A and B. In the presence of reducing agents, SDS-polyacrylamide gel electrophoresis resolves the FSH-releasing substance into two subunits which are identical in their migration behaviour to the reduced beta-subunits of inhibins A and B. Based on the N-terminal sequence data and Mr of the intact and reduced molecules, we propose that the FSH-releasing substance, which is active in picomolar concentrations, is a heterodimeric protein composed of the two beta-subunits of inhibins A and B linked by interchain disulphide bond(s). The structural organization of the FSH-releasing substance is homologous to that of transforming growth factor-beta (TGF-beta), which also possesses FSH-releasing activity in the same bioassay. We suggest that the substance be called activin to signify the fact that it has opposite biological effects to inhibin.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid.

            A variety of hypophysiotropic peptides or proteins have been reported to be present in mammalian gonads. Inhibin, a hormone that under most circumstances selectively suppresses the secretion of follicle-stimulating hormone (FSH) but not luteinizing hormone (LH), has been isolated from the gonadal fluids of several species and characterized as a heterodimeric protein consisting of alpha- and beta-polypeptides associated by disulphide bonds. The complete amino-acid sequences of the precursors of porcine and human inhibin alpha-subunits and two distinct porcine inhibin beta-subunits (beta A and beta B) have been deduced from complementary DNA sequences. Gonadotropin releasing peptides have also been found in the gonad and have generally been shown to be active in radioreceptor assays for gonadotropin releasing hormone (GnRH) but to exhibit different chromatographic and immunological characteristics from those of GnRH. During our purification of inhibin from porcine follicular fluid, we noted fractions that could stimulate the secretion of FSH by cultured anterior pituitary cells. We report here the purification of an FSH releasing protein (FRP) and its characterization by SDS-polyacrylamide gel electrophoresis under non-reducing and reducing conditions and by partial sequence analysis. Our results indicate that porcine gonadal FRP is a homodimer consisting of two inhibin beta A-chains linked by disulphide bonds. FRP is highly potent (50% effective concentration (EC50) approximately 25 pM) in stimulating the secretion and biosynthesis of FSH but not of LH or any other pituitary hormone. In contrast to the effects of GnRH and other reported gonadal gonadotropin releasing fractions, the action of FRP is not mediated by GnRH receptors.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone.

              A Mr 35,000 protein with follicle-stimulating hormone release-inhibitory activity was isolated from porcine ovarian follicular fluid by heparin-Sepharose affinity chromatography, gel filtration on Sephacryl S-200, and multiple steps of high-performance liquid chromatography. The isolated molecule is highly enriched in cysteines and is composed of a single polypeptide chain. In addition, it has no sequence homology with the previously characterized follicular fluid inhibins, which are heterodimeric proteins of Mr 32,000 with follicle-stimulating hormone release-inhibiting activity. This protein specifically inhibits the basal secretion of follicle-stimulating hormone, but not that of luteinizing hormone, in the rat anterior pituitary monolayer culture system with a half-maximal effective dose of 2.5-6.0 ng/ml. Another form of the molecule of Mr 32,000 present in much lower concentration in follicular fluid was also isolated. It may differ from the Mr 35,000 form in glycosylation or carboxyl-terminal truncation. We suggest that this compound be called "follistatin" to signify its structural difference from inhibin.
                Bookmark

                Author and article information

                Comments

                Comment on this article